A First In Human Study Of PF-00184562 In Healthy Volunteers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
The purposes of this study are: * To determine the safety, tolerability and pharmacokinetics of single doses of PF-00184562; and * To explore the exposure-response relationship of neuropsychometric and tolerability measures of PF-00184562 compared to olanzapine.
Epistemonikos ID: 0d86b9286d7e7c85fa7bd0c9578d2807d65f068d
First added on: May 04, 2024